Cue Biopharma Inc (NASDAQ:CUE)

9.00
Delayed Data
As of Jan 21
 +0.17 / +1.93%
Today’s Change
8.31
Today|||52-Week Range
18.42
-20.42%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$317.6M

Company Description

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded by Ronald D. Seidel III, Steven Almo, and, Rodolfo Chaparro on December 31, 2014 and is headquartered in Cambridge, MA.

Contact Information

Cue Biopharma, Inc.
21 Erie Street
Cambridge Massachusetts 02139
P:(617) 949-2680
Investor Relations:

Employees

Shareholders

Other institutional31.45%
Mutual fund holders21.64%
Individual stakeholders12.23%

Top Executives

Daniel R. PasseriChief Executive Officer & Director
Anish SuriPresident & Chief Scientific Officer
Kerri-Ann MillarChief Financial & Accounting Officer
Ronald D. SeidelEVP, Head-Research & Development
Kenneth J. PientaChief Medical Officer